Chance for Tasmanian poppy farms to go global

Updated March 6 2015 - 8:18am, first published 8:00am
INVESTMENT IN THE FUTURE:   The possible sale of GlaxoSmithKline Australia’s opiates division to Sun Pharma is a vote of confidence in Tasmania according to Primary Industries Minister Jeremy Rockliff. Picture: Meg Windram.
INVESTMENT IN THE FUTURE: The possible sale of GlaxoSmithKline Australia’s opiates division to Sun Pharma is a vote of confidence in Tasmania according to Primary Industries Minister Jeremy Rockliff. Picture: Meg Windram.

TASMANIAN poppy growers' crops will be more part of a global market if Indian pharmaceutical company Sun Pharma buys GlaxoSmithKline Australia's opiates division.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Tamworth news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.